← Eichor
Study identifier: NCT07711847 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

Condition: Invasive Breast Cancer Early Stages · Ductal Carcinoma In Situ, DCIS  ·  Sponsor: HeroSupport SA

PhaseNA
Planned participants30
Who can joinFemale, 40 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to find out whether using a personalized breast holder (called VENUS SHELL™) can improve positioning and patient comfort during prone radiotherapy (radiotherapy given while the patient lies on her stomach). The main goals of the study are: * To confirm that using the VENUS SHELL™ is safe and effective * To assess whether the VENUS SHELL™ helps deliver accurate radiation treatment in a faster and more comfortable way Participants will: * Attend a study visit before radiotherapy to have a breast surface scan (no radiation) and enable the production of their personalized VENUS SHELL™ * Use their VENUS SHELL™ during radiotherapy planning and treatment * Be asked to complete questionnaires about their comfort

This description comes directly from the study's public registry record.

Talk to the study team

Giovanna Dipasquale  ·  +41(0)783349987  ·  giovanna@herosupport.ch

Cristina Riccadonna  ·  +41(0)223794650  ·  clinical@herosupport.ch

Always discuss trial participation with your own doctor first.

Locations (1)

NYU Grossman School of MedicineNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07711847